1513. Medically Attended Respiratory Syncytial Virus Hospitalizations (RSVH) and All-Cause Bronchiolitis Hospitalizations (BH) Among Children Aged ≤ 24 Months at RSV Season Start With Higher-Risk Congenital Heart Disease (CHD) Before and After the 2014 American Academy of Pediatrics (AAP) Policy

BACKGROUND: In 2014, the AAP stopped recommending palivizumab for use in children with hemodynamically significant CHD (hs-CHD) aged 12 to 24 months at the RSV season start. This analysis investigates the impact of the 2014 AAP policy on the contemporary burden of RSVH and BH in children with CHD fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fergie, Jaime, Gonzales, Tara, Suh, Mina, Jiang, Xiaohui, Fryzek, Jon, Howard, Ashley, Bloomfield, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777864/
http://dx.doi.org/10.1093/ofid/ofaa439.1694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777864/
http://dx.doi.org/10.1093/ofid/ofaa439.1694

Ejemplares similares